Hemogenyx Pharmaceuticals Plc (HEMO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HEMO.LN | ||||
| Company | Hemogenyx Pharmaceuticals Plc | ||||
| Price Information | |||||
| Exchange | LSE | ||||
| Open | 790.000 | ||||
| High | 880.000 | ||||
| Low | 723.000 | ||||
| Latest | 824.545 | ||||
| Change | +54.045 | ||||
| % Change | +7.01% | ||||
| Volume | 19,877 | ||||
| 20-Day Average Volume | 16,706 | ||||
| Previous Close | 770.500 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 721.052 | ||||
| 20-Day Raw Stochastic | 75.89% | ||||
| 20-Day Relative Strength | 56.71 | ||||
| Weighted Alpha | -13.11 | ||||
| Today's Opinion | 24% Sell | ||||
| Previous Opinion | 56% Sell | ||||
| Last Month's Opinion | 40% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.20% since 06/05/26 | ||||
| Low | 702.000 on 06/10/26 | ||||
| High | 880.000 on 06/12/26 | ||||
| 1-Month | |||||
| %Chg | +29.65% since 05/12/26 | ||||
| Low | 615.000 on 05/13/26 | ||||
| High | 880.000 on 06/12/26 | ||||
| 3-Month | |||||
| %Chg | -25.88% since 03/12/26 | ||||
| Low | 601.000 on 05/12/26 | ||||
| High | 1,200.000 on 03/17/26 | ||||
| 6-Month | |||||
| %Chg | +43.65% since 12/12/25 | ||||
| Low | 546.000 on 01/06/26 | ||||
| High | 1,220.000 on 02/26/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 56,134 | ||||
| Shares Outstanding, K | 6,800 | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | -9,760,364 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||